“…Previous studies have suggested that FGF9 functions as an autocrine/paracrine growth factor for neuron cells (Giri et al, 1999;Kanda et al, 2000;Song and Slack, 1996), fibroblasts , and endometrial stromal cells , and as an oncogene for NIH3T3 fibroblast cells (Miyamoto et al, 1993). In addition, aberrant expression of FGF9 has been associated with several diseases: brain tumor (Todo et al, 1998), prostate cancer , endometriosis (Wing et al, 2003), and primary synovial chondromatosis (PSC) (Robinson et al, 2000).…”